Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General business news Vertex acquires LitCon Group to enhance forensic and technical consulting services In a move to further cement its position as a leader in forensic accounting and technical consulting, The… byPallavi MadhirajuDecember 4, 2024